Cargando…
The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation
Rhabdomyosarcoma (RMS) is the most common type of pediatric soft tissue sarcoma. The MET receptor has an important role in the biology of RMS, and its overexpression and hyperactivation correlate with the metastatic ability of RMS. Consequently, interfering with MET expression or functionality may c...
Autores principales: | Miekus, K, Lukasiewicz, E, Jarocha, D, Sekula, M, Drabik, G, Majka, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563987/ https://www.ncbi.nlm.nih.gov/pubmed/23328666 http://dx.doi.org/10.1038/cddis.2012.199 |
Ejemplares similares
-
Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression
por: Skrzypek, Klaudia, et al.
Publicado: (2015) -
Downregulation of the CXCR4 receptor inhibits cervical carcinoma metastatic behavior in vitro and in vivo
por: SEKUŁA, MAŁGORZATA, et al.
Publicado: (2014) -
MET receptor is a potential therapeutic target in high grade cervical cancer
por: Miekus, Katarzyna, et al.
Publicado: (2015) -
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma
por: Saini, Masum, et al.
Publicado: (2018) -
C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
por: Marona, Paulina, et al.
Publicado: (2019)